CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats - Wikidata - awgldk - TriplyDB

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

http://www.wikidata.org/entity/Q30485809

about

A role for brain stress systems in addiction.Role of kappa-opioid receptors in stress and anxiety-related behavior.Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2 Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.Progress in corticotropin-releasing factor-1 antagonist development.The role of CRF and CRF-related peptides in the dark side of addiction.Molecular and genetic substrates linking stress and addiction Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.Reduction of adult hippocampal neurogenesis confers vulnerability in an animal model of cocaine addiction Neurobiology of dysregulated motivational systems in drug addiction.Corticotropin releasing factor: a key role in the neurobiology of addiction The dark side of emotion: the addiction perspective Translational and reverse translational research on the role of stress in drug craving and relapse.Baclofen has opposite effects on escalation of cocaine self-administration: increased intake in rats selectively bred for high (HiS) saccharin intake and decreased intake in those selected for low (LoS) saccharin intake.The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.The dark side of food addiction.Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice Addiction and brain reward and antireward pathways.Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice.Bidirectional regulation over the development and expression of loss of control over cocaine intake by the anterior insula.A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats.A neuropeptide-centric view of psychostimulant addiction Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic Corticotropin Releasing Factor in the Anterior and Posterior Ventral Tegmental Area.Effects of cocaine hydrolase on cocaine self-administration under a PR schedule and during extended access (escalation) in rats.Motivational Processes Underlying Substance Abuse Disorder.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats.Review. Neurobiological mechanisms for opponent motivational processes in addiction.A review of preclinical research demonstrating that drug and non-drug reinforcers differentially affect behavior

P2860

Q24649537-02DB7EB6-0FE4-48E2-848C-E5F5D8D58C8E Q26991739-5E9418AB-5381-414C-9F98-A1DF5437C511 Q27014879-3D237A23-434C-44F0-BF7E-5FA4EC9B3197 Q28573866-8C96A888-4BAB-40F0-B2C6-036E2A8AB0B6 Q28582150-9F00FC20-6A12-4C3E-9C3D-991E7A12F2FB Q30431860-D900BF3F-C6F1-4E6C-95A2-09A4C4A2F97F Q30455336-3BE3226D-F867-4AE6-B85F-22CCE8FB3688 Q30461988-FAD319A0-ADE5-473E-87C0-4B01145B611F Q30467194-549B858F-752B-43B9-A59A-AEF9D9FC9D22 Q30468942-76846922-4D83-4CB4-B114-5B0C8F4EF564 Q30475627-3A101DE4-6552-40FA-A967-3450EA8F92F2 Q30476985-B8DC88A0-BF7D-4506-825C-F0D5D38ABB74 Q30476986-389639B3-82AF-4817-8C14-2F0040D4172A Q30488917-63D14704-2D45-4125-B780-6111664570CC Q33572392-B97933BC-B544-4D0F-95C8-59F7C7147993 Q33575214-7458F645-8C9B-4307-BDDE-A168CA97CD10 Q33616639-7E5FE1A8-DB58-4974-8BA8-D28D5313F895 Q33643476-DD8F5A3D-32B1-430D-BD80-F98104F5B7C8 Q33750555-A2390B45-7458-4B0B-AA21-6A8C5064CEC7 Q33915824-F7F81DC7-4607-47BF-9B17-8386C37B4F31 Q34421204-9631EA93-4CF1-4173-8371-4F46BAD2AE23 Q35235813-3A57FF8C-D006-4E4A-8BAF-9CC2766808BC Q35332832-3DAF218E-BC11-44C0-B025-5F97C3CC9F03 Q35508010-B75BAFB4-A0F5-49C7-B194-E99D1258B480 Q35624709-684D8DAD-AE93-4717-AF26-5A89B16A4349 Q35832522-9598E14B-6310-4BC6-81F0-3C2FD201B2C9 Q35833732-526929DB-9D0B-4706-B53D-BE4E6B33676B Q35839414-9E431935-4A53-4FB3-8BD0-57BC1588F7F5 Q35995170-3C80BADD-291D-4C4D-B713-B76B249CB852 Q36221019-322594B8-CD90-4F8E-B612-5A283E971DEA Q36335305-AE4B7E93-174A-4AA2-BE5A-1BEBEAB3AEEA Q36539822-14B8F636-B3DA-466B-AEA0-8959002A4DCE Q36741898-CBD29606-4FCD-4384-B3C1-6A10F3C5AB3E Q36768435-AC291A89-2850-4BAA-AE74-1C05486E3D0D Q36781699-D667C1D1-9B2D-4980-899A-7302E8FF1EC5 Q36853330-1583AA6F-23A9-41C5-8429-0F52CF84CCCC Q36900018-03791A35-FF71-40A5-8CA8-D737D59DF350 Q36982413-E6870CD2-D449-4911-8C08-06F358124098 Q37024157-82DA2D75-B2C0-4681-BFC4-C736C3182EFD Q37029260-7B6654C2-777A-41BC-827B-D3725AF67E7C

P2860

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

http://www.wikidata.org/entity/Q30485809

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@ast

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@en

type

label

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@ast

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@en

prefLabel

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@ast

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@en

P1433

Q30485809-F8766BDF-2659-4B53-A27D-E37DADA8B8A4

P1476

Q30485809-B90F046E-F1AE-48C4-BAC0-9E09E8AF197E

P2093

Q30485809-3358F3C3-57B9-475B-BEAF-4ABD11B95AB3

Q30485809-534E3B5A-4ECF-4918-8797-3FC14A72B394

Q30485809-973D216D-F799-4187-8AD4-4A12B15C5039

Q30485809-AA85D663-912C-422B-98CA-9DC911744794

Q30485809-B2441834-C6B3-448C-9F8F-C194DA8D7ABC

Q30485809-DAA63701-4FFD-4B25-ACBA-C7D585413375

P2860

Q30485809-0A4947CE-A162-4E99-A485-974C38A76AFA

Q30485809-0DDDC5D1-C92E-4E24-944A-2DF75EB6609D

Q30485809-0DE4AB6E-127E-40A1-8298-416B9D50CEFF

Q30485809-0FA0503B-37ED-42EB-98FB-54C8F9FBBD28

Q30485809-13CEF996-58E1-4604-8865-76249C36803B

Q30485809-14052665-FF03-4839-8FC8-5C89340D4EF0

Q30485809-1D2519CA-F703-46E8-A071-F16248DF464A

Q30485809-1FC91DAA-706E-4D4C-BA53-71903D595372

Q30485809-24FF96B6-331A-404F-ABF8-56C7C997DEDD

Q30485809-269A5E9B-5D7F-4CF7-BC41-C1CD62108364

P2888

Q30485809-D622AAD4-7FA4-4C0A-BFE8-47D5E74DBB3B

P304

Q30485809-A497DAE0-E62D-4160-8E94-8028DD3EF14D

P31

Q30485809-57F36169-1901-4025-B4F0-26F00DE299F4

P356

Q30485809-0F731579-AE82-4FC7-A811-D2592849E25E

P433

Q30485809-E5E1438C-2CDD-4DA2-AC75-73229334C132

P478

Q30485809-84BE50EF-D1C6-4764-8D80-D7DAAFD6F081

P577

Q30485809-56AB7576-7496-4B9C-BDBB-8BED649CB825

P5875

Q30485809-06894CEE-7644-4DE8-946F-4CEE1DF9CF5B

P6179

Q30485809-BBABF623-9F43-4670-A66A-E2134EFCCB09

P698

Q30485809-81ACB9B4-7DF0-44EA-8116-EADDD9F1D231

P921

Q30485809-253912C7-0E65-4A92-AA59-8194760D9C8A

P932

Q30485809-92555FEC-AF4E-4CA6-9103-4B6DFE11C62D

P356

S00213-007-0983-9

P1433

Psychopharmacology

P1476

CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats

@en

P2093

Benjamin Boutrel

http://www.w3.org/2001/XMLSchema#string

Eric P Zorrilla

http://www.w3.org/2001/XMLSchema#string

George F Koob

http://www.w3.org/2001/XMLSchema#string

Laura E O'Dell

http://www.w3.org/2001/XMLSchema#string

Sheila E Specio

http://www.w3.org/2001/XMLSchema#string

Sunmee Wee

http://www.w3.org/2001/XMLSchema#string

P2860

Statistics review 9: one-way analysis of variance

Drug abuse: hedonic homeostatic dysregulation

Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin

Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats

Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats.

Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress?

Corticotropin-releasing factor, norepinephrine, and stress.

Stress, corticotropin-releasing factor, and drug addiction.

P2888

s00213-007-0983-9

P304

473-482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-007-0983-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

196

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

226487413

http://www.w3.org/2001/XMLSchema#string

P6179

1016306320

http://www.w3.org/2001/XMLSchema#string

P698

17965976

http://www.w3.org/2001/XMLSchema#string

P921

P932

2769571

http://www.w3.org/2001/XMLSchema#string